Intellia Therapeutics Head office building

SEC Filing
Details

Document Details

Form
Filing Date
Jul 11, 2017
Document Date
Jul 6, 2017
Form Description

Statement of changes in beneficial ownership of securities

Filing Group
3,4,5
Company
Intellia Therapeutics
Issuer
Intellia Therapeutics, Inc.